Both NfL and t-tau are biomarkers of neurodegeneration attributed to many neurodegenerative diseases, including Alzheimer disease.33,34 However, increased plasma levels of NfL and t-tau may be attributable to different risk factors and pathways to neurodegenerative diseases. The gene discussed is NEFL; the disease is early-onset autosomal dominant Alzheimer disease.